Optical Coherence Tomography Angiography Findings in Ocular Toxoplasmosis with Multiple Recurrences

References

• Feliciano-Alfonso JE, Muñoz-Ortiz J, Marín-Noriega MA, et al. Safety and efficacy of different antibiotic regimens in patients with ocular toxoplasmosis: systematic review and meta-analysis. Syst Rev. 2021;10(1):1–4. doi:10.1186/s13643-021-01758-7
   Web of Science ®Google Scholar
• Grigg ME, Dubey JP, Nussenblatt RB. Ocular toxoplasmosis: lessons from Brazil. Am J Ophthalmol. 2015;159(6):999–1001. doi:10.1016/j.ajo.2015.04.005
   Web of Science ®Google Scholar
• Greigert V, Bittich-Fahmi F, Pfaff AW, Taylan Ozkan A. Pathophysiology of ocular toxoplasmosis: facts and open questions. PLoS Negl Trop Dis. 2020;14(12):e0008905. doi:10.1371/journal.pntd.0008905
   PubMed Web of Science ®Google Scholar
• La Distia Nora R, Sitompul R, Bakker M, et al. Tuberculosis and other causes of uveitis in Indonesia. Eye. 2018;32(3):546–554. doi:10.1038/eye.2017.231
   PubMed Web of Science ®Google Scholar
• Smith JR, Ashander LM, Arruda SL, et al. Pathogenesis of ocular toxoplasmosis. Prog Retin Eye Res. 2021;1(81):100882.
   Google Scholar
• Kalogeropoulos D, Sakkas H, Mohammed B, et al. Ocular toxoplasmosis: a review of the current diagnostic and therapeutic approaches. Int Ophthalmol. 2021;9:1–27.
   Google Scholar
• Vezzola D, Allegrini D, Borgia A, et al. Swept-source optical coherence tomography and optical coherence tomography angiography in acquired toxoplasmic chorioretinitis: a case report. J Med Case Rep. 2018;Dec;12(1):1–4.
   Google Scholar
• Kalogeropoulos D, Kalogeropoulos C, Sakkas H, et al. Pathophysiological aspects of ocular toxoplasmosis: host-parasite interactions. Ocul Immunol Inflamm. 2022;30(3):560–569. doi:10.1080/09273948.2021.1922706
   PubMed Web of Science ®Google Scholar
• Papadia M, Aldigeri R, Herbort CP. The role of serology in active ocular toxoplasmosis. Int Ophthalmol. 2011;31(6):461–465. doi:10.1007/s10792-011-9507-z
   PubMedGoogle Scholar
• Ozgonul C, Besirli CG. Recent developments in the diagnosis and treatment of ocular toxoplasmosis. Ophthalmic Res. 2017;57(1):1–2. doi:10.1159/000449169
   PubMed Web of Science ®Google Scholar
• Invernizzi A, Cozzi M, Staurenghi G. Optical coherence tomography and optical coherence tomography angiography in uveitis: a review. Clin Experiment Ophthalmol. 2019;47(3):357–371. doi:10.1111/ceo.13470
   PubMed Web of Science ®Google Scholar
• Koustenis A, Harris A, Gross J, Januleviciene I, Shah A, Siesky B. Optical coherence tomography angiography: an overview of the technology and an assessment of applications for clinical research. Br J Ophthalmol. 2017;101:16–20. doi:10.1136/bjophthalmol-2016-309389
   PubMed Web of Science ®Google Scholar
• Azar G, Favard C, Salah S, Brézin A, Vasseur V, Mauget-Faÿsse M. Optical coherence tomography angiography analysis of retinal and choroidal vascular networks during acute, relapsing, and quiescent stages of macular toxoplasma retinochoroiditis. Biomed Res Int. 2020;2020:1–8. doi:10.1155/2020/4903735
   Web of Science ®Google Scholar
• Lijeskić O, Štajner T, Srbljanović J, et al. Postnatal ocular toxoplasmosis in immunocompetent patients. J Infect Dev Ctries. 2021;15(10):1515–1522. doi:10.3855/jidc.14824
   Web of Science ®Google Scholar
• Perez AL, Lozada RA, Emanuelli A, Oliver AL. Optical coherence tomography angiography findings in macular toxoplasma retinochoroiditis: a case report. Am J Ophthalmol Case Rep. 2020;1(19):100764. doi:10.1016/j.ajoc.2020.100764
   Google Scholar
• Gerges TK. Ocular toxoplasmosis: an update on diagnosis, multimodal imaging and therapy. In: Infectious Eye Diseases: Recent Advances in Diagnosis and Treatment. Books on Demand; 2021:81.
   Google Scholar
• Onal S, Tugal-Tutkun I, Neri P, Herbort C. Optical coherence tomography imaging in uveitis. Int Ophthalmol. 2014;34(2):401–435. doi:10.1007/s10792-013-9822-7
   PubMed Web of Science ®Google Scholar
• Tranos P, Karasavvidou EM, Gkorou O, Pavesio C. Optical coherence tomography angiography in uveitis. J Ophthalmic Inflamm Infect. 2019;9(1):1–3. doi:10.1186/s12348-019-0190-y
   Web of Science ®Google Scholar
• Cunningham ET, Smit DP, Zierhut M. Imaging ocular toxoplasmosis. Ocul Immunol Inflamm. 2022;30(3):525–526. doi:10.1080/09273948.2022.2086395
   PubMed Web of Science ®Google Scholar
• Türkcü FM, Şahin A, Yüksel H, Şahin M, Karaalp Ü. OCTA imaging of choroidal neovascular membrane secondary to toxoplasma retinochoroiditis. Ophthalmic Surg Lasers Imaging Retina. 2017;48(6):509–511. doi:10.3928/23258160-20170601-11
   PubMed Web of Science ®Google Scholar
• Park JH, Lee SY, Lee EK. Morphological characteristics of ocular toxoplasmosis and its regression pattern on swept-source optical coherence tomography angiography: a case report. BMC Ophthalmol. 2019;19(1):1–6. doi:10.1186/s12886-019-1209-8
   Web of Science ®Google Scholar
• de Oliveira Dias JR, Campelo C, Novais EA, et al. New findings useful for clinical practice using swept-source optical coherence tomography angiography in the follow-up of active ocular toxoplasmosis. Int J Retin Vitr. 2020;6(1):1. doi:10.1186/s40942-020-00231-2
   Google Scholar
• Furtado JM, Ashander LM, Mohs K, Chipps TJ, Appukuttan B, Smith JR. Toxoplasma gondii migration within and infection of human retina. PLoS One. 2013;8(2):e54358. doi:10.1371/journal.pone.0054358
   PubMed Web of Science ®Google Scholar
• Rodriguez Fernandez V, Casini G, Bruschi F. Ocular toxoplasmosis: mechanisms of retinal infection and experimental models. Parasitologia. 2021;1(2):50–60. doi:10.3390/parasitologia1020007
   Google Scholar
• Drewry LL, Jones NG, Wang Q, Onken MD, Miller MJ, Sibley LD. The secreted kinase ROP17 promotes Toxoplasma gondii dissemination by hijacking monocyte tissue migration. Nature Microbiol. 2019;4(11):1951–1963. doi:10.1038/s41564-019-0504-8
   Web of Science ®Google Scholar